Yttrium-90 (90Y) brachytherapy for squamous carcinoma: Treatment of the conjunctiva, cornea, and sclera
<sup>90</sup>Y brachytherapy demonstrated efficacy as a single-surgery, minimally invasive, outpatient irradiation for squamous carcinoma of the ocular surface. While short-term results were promising, long-term follow-up monitoring for side-effects and recurrence are essential.
Authors
- Miguel A. Materin (ORCID: https://orcid.org/0000-0001-9097-9512)
- Arpita Maniar (ORCID: https://orcid.org/0000-0003-1325-1274)
- Junzo Chino (ORCID: https://orcid.org/0000-0002-3633-9685)
- Sheridan Meltsner
- Paul T. Finger (ORCID: https://orcid.org/0000-0002-8111-3896)
Institutions
- Duke University (US)
- Eye Cancer Foundation (US)
Publication Details
- Journal
- American Journal of Ophthalmology Case Reports
- Published
- 2024-08-31
- DOI
- https://doi.org/10.1016/j.ajoc.2024.102157
- Citations
- 1
- Primary Topic
- Ocular Oncology and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.54